Related Experiment Videos
[Rhabdomyosarcoma: morphology and cellular differentiation]
Abstract:
544 malignant soft tissue tumors have been collected at the Pediatric Tumor Registry in Kiel including 300 cases of rhabdomyosarcoma (55%). In 237 of the 300 cases the diagnosis is certain. Liposarcoma and malignant fibrous histiocytoma which are typical tumors of adult age are rare in our material. Among rhabdomyosarcomas embryonal rhabdomyosarcoma (eRMS) clearly predominates accounting for almost 72% of all rhabdomyosarcomas. Differentiation of tumor cells in eRMS may vary considerably. Therefore, three groups of eRMS were distinguished and analyzed for clinico-pathologic features: 1. Primitive eRMS with less than 10 rhabdomyoblasts. 2. Intermediate eRMS with 10-50% rhabdomyoblasts. 3. Well differentiated eRMS with greater than 50% rhabdomyoblasts. By immunohistochemistry, vimentin positive cells were found in all three groups. The number of desmin positive cells depended upon the grade of differentiation. Thus, there were more desmin positive cells in well differentiated eRMS. Primitive and well differentiated eRMS were predominantly located in the head and neck area, intermediate eRMS in the abdomen. Primitive eRMS were noted in higher stages than tumors of the other two groups. Response to chemotherapy as evaluated in the 7th week of treatment was better in well differentiated eRMS. Moreover, patients of this group achieved more often complete remission. It is concluded from the present study that differentiation in eRMS may have an influence on the clinical presentation and clinical course of the disease. Therefore, this question should be investigated in more detail in a larger prospective study.
Insights
Tumor cell differentiation in embryonal rhabdomyosarcoma (eRMS) impacts clinical presentation and treatment response. Well-differentiated eRMS shows better chemotherapy outcomes, suggesting differentiation is key for prognosis.
Area of Science:
- Pediatric Oncology
- Skeletal Muscle Tumors
- Cancer Cell Biology
Context:
- The Kiel Pediatric Tumor Registry collected 544 malignant soft tissue tumors, with 300 (55%) being rhabdomyosarcomas.
- Embryonal rhabdomyosarcoma (eRMS) is the predominant subtype (72%) in this pediatric cohort.
- Adult-type tumors like liposarcoma and malignant fibrous histiocytoma were rare.
Purpose:
- To analyze clinico-pathologic features of embryonal rhabdomyosarcoma (eRMS) based on tumor cell differentiation.
- To investigate the relationship between eRMS differentiation, tumor location, stage, and response to chemotherapy.
Summary:
- eRMS were categorized into primitive (<10% rhabdomyoblasts), intermediate (10-50%), and well-differentiated (>50%).
- Immunohistochemistry showed vimentin in all groups and desmin correlating with differentiation.
- Tumor location varied by differentiation: head/neck for primitive and well-differentiated, abdomen for intermediate.
- Primitive eRMS presented at higher stages, while well-differentiated eRMS responded better to chemotherapy, achieving more complete remissions.
Impact:
- Demonstrates that the degree of differentiation in eRMS influences clinical presentation and disease course.
- Highlights the potential prognostic significance of eRMS differentiation.
- Suggests further investigation in larger prospective studies to confirm these findings.